Under construction – not a live service

Skip to content

Frontlight Research

Trial site

Leader Research

Hamilton, Ontario, CanadaNot linked to an institution yet

1running trials
5closed trials
0trials confirmed by the site in the last 60 days
–languages not stated

The site has not confirmed any trial yet.

Running trials

Active, not recruiting
A Study to Assess the Efficacy and Safety of Ruxolitinib Cream in Children and Adolescents (6 to <18 Years Old) With Moderate Atopic Dermatitis
NCT06832618· Phase 3· Source

Researchers

No researcher is linked here yet.

Closed trials

Completed
A Study With Self-administered Rocatinlimab in Adolescent and Adult Participants With Moderate-to-severe Atopic Dermatitis
NCT06224192· Phase 3· Source
Completed
A Study to Assess the Safety, Tolerability, and Efficacy of Rocatinlimab in Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD)
NCT05633355· Phase 3· Source
Terminated
An Efficacy and Safety Study of RPT193 in Adults With Atopic Dermatitis
NCT05399368· Phase 2· Source
Completed
A Study Evaluating Rocatinlimab in Moderate-to-severe Atopic Dermatitis (ROCKET-IGNITE)
NCT05398445· Phase 3· Source
Completed
A Study to Assess the Efficacy and Safety of Ruxolitinib Cream in Children With Atopic Dermatitis (TRuE-AD3)
NCT04921969· Phase 3· Source

Site data: ClinicalTrials.govUpdated 5 Nov 2026

Report an error

Under construction, not live – Leader Research: trial site – Frontlight Research